Long-term outcome of invasive electrophysiological studies and catheter ablation in patients with patent foramen ovale and atrial septal defect–A single-center retrospective cohort study
In patients with ASD and PFO, RFCA is safe and acutely effective but followed by arrhythmia recurrence in a quarter of patients. The evolving arrhythmic substrate highlights the need for early intervention strategies and emerging technologies to optimize long-term outcomes in this patient population.
Authors
- Bert Vandenberk (ORCID: https://orcid.org/0000-0001-8296-920X)
- Els Troost (ORCID: https://orcid.org/0000-0001-7920-8661)
- Pieter De Meester (ORCID: https://orcid.org/0000-0002-3865-0506)
- Alexander Van De Bruaene (ORCID: https://orcid.org/0000-0002-0469-8640)
- Joris Ector (ORCID: https://orcid.org/0000-0002-1460-7837)
- Werner Budts (ORCID: https://orcid.org/0000-0001-5850-5413)
- Peter Haemers (ORCID: https://orcid.org/0000-0002-3024-1281)
- Paul Lewandowski (ORCID: https://orcid.org/0000-0001-8135-6217)
- Thomas Rosseel (ORCID: https://orcid.org/0000-0002-9688-3033)
- Christophe Garweg (ORCID: https://orcid.org/0000-0002-2173-1035)
Institutions
- Universitair Ziekenhuis Leuven (BE)
- KU Leuven (BE)
Publication Details
- Journal
- International Journal of Cardiology Congenital Heart Disease
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1016/j.ijcchd.2025.100615
- Primary Topic
- Cardiovascular and Diving-Related Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00